enGene Holdings Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
enGene Holdings Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2022 to Q3 2024.
  • enGene Holdings Inc. Share-based Payment Arrangement, Expense for the quarter ending October 31, 2024 was $1.66M, a 50.6% decline year-over-year.
  • enGene Holdings Inc. Share-based Payment Arrangement, Expense for the twelve months ending October 31, 2024 was $5.32M, a 54.3% increase year-over-year.
  • enGene Holdings Inc. annual Share-based Payment Arrangement, Expense for 2024 was $5.32M, a 54.3% increase from 2023.
  • enGene Holdings Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.45M, a 2874% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.32M $1.66M -$1.7M -50.6% Aug 1, 2024 Oct 31, 2024 10-K 2024-12-19
Q2 2024 $7.02M $1.46M +$1.42M +3846% May 1, 2024 Jul 31, 2024 10-Q 2024-09-10
Q1 2024 $5.6M $1.92M +$1.88M +4815% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $3.72M $291K +$271K +1355% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 $3.45M $3.35M Aug 1, 2023 Oct 31, 2023 10-K 2024-12-19
Q2 2023 $37K May 1, 2023 Jul 31, 2023 10-Q 2024-09-10
Q1 2023 $39K Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $20K Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.